Insulin glargine and lixisenatide and Stadol injection
Determining the interaction of Insulin glargine and lixisenatide and Stadol injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: butorphanol
Brand name: Stadol NS, Stadol
Synonyms: Stadol NS (nasal), Stadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Stadol NS nasal
- Insulin glargine and lixisenatide-Stagesic
- Insulin glargine and lixisenatide-Stahist AD
- Insulin glargine and lixisenatide-Stahist AD (Chlorcyclizine and Pseudoephedrine Liquid)
- Insulin glargine and lixisenatide-Stahist AD (Chlorcyclizine and Pseudoephedrine Tablets)
- Insulin glargine and lixisenatide-Stalevo
- Stadol injection-Insulin glargine and lixisenatide Subcutaneous
- Stadol injection-Insulin glargine, recombinant Subcutaneous
- Stadol injection-Insulin glulisine
- Stadol injection-Insulin Glulisine (Cartridges and Pens)
- Stadol injection-Insulin Glulisine (Vials)
- Stadol injection-Insulin glulisine Subcutaneous